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Basement membranes (BMs) are thin sheets of specialized extra-
cellular matrix (ECM), underlying all epithelia, and surrounding
muscle, endothelial, fat and Schwann cells as well as the whole
central nervous system. The function of BMs is to provide struc-
tural support, divide tissues into compartments and also to regu-
late cellular functions. The major structural components of BMs
are sheets of laminins (Lm) and type IV collagens, which are
bridged by nidogen into a functional BM structure. Out of the var-
ious BM components, Lms have been shown to be the most
important regulators of cellular functions [1–3]. Lms are trimeric
glycoproteins composed of ,  and  chain [3]. Among 15 rec-
ognized Lms, embryonic Lm-111 (111) and Lm-511 (511)
are crucial during early mouse embryogenesis for the survival and
development of embryonic epithelial cells [4]. Null mutations in
Lm 1 or Lm 1 chains are lethal at E5.5 due to non-functional
embryonic BM and Reichert’s membrane [5, 6]. Also, mouse
embryos lacking Lm 1 die at E7.5 due to the absence of func-
tional Reichert’s membrane [7].
Integrins are heterodimeric cell membrane receptors, consist-
ing of non-covalently linked  and  subunits. They mediate
Laminin isoforms in human embryonic stem cells: 
synthesis, receptor usage and growth support
Sanna Vuoristo a, b, *, Ismo Virtanen c, Minna Takkunen c, Jaan Palgi a, Yamato Kikkawa d, 
Patricia Rousselle e, Kiyotoshi Sekiguchi f, Timo Tuuri a, Timo Otonkoski a, b
a Biomedicum Stem Cell Center, University of Helsinki, Helsinki, Finland
b Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
c Institute of Biomedicine/Anatomy, University of Helsinki, Helsinki, Finland
d Laboratory of Clinical Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, Japan
e Institut de Biologie et Chimie des Protéines, Unité Mixte de Recherche, Institut Fédératif de Recherche 
BioSciences Lyon-Gerland, Lyon, France
f Laboratory of Extracellular Matrix Biochemistry, Institute for Protein Research, Osaka University, Suita, Osaka, Japan
Received: October 2, 2008; Accepted: December 17, 2008
Abstract
To reveal the functional intrinsic niche of human embryonic stem cells (hESC) we examined the production of basement membrane (BM)
proteins and the presence of their receptors in feeder-free cell culture conditions. In addition, we investigated binding of hESCs to puri-
fied human BM proteins and identified the receptors mediating these contacts. Also, we tested whether purified human laminin (Lm)
isoforms have a role in hESC self-renewal and growth in short-term cultures. The results show that hESCs synthesize Lm 1 and Lm 5
chains together with Lm 1 and 1 chains suggesting the production of Lms-111 and -511 into the culture medium and deposits on
cells. hESCs contain functionally important integrin (Int) subunits, Int 1, 3, 6, 5, 5 and V, as well as the Lm 5 receptor, Lutheran
(Lu) glycoprotein and its truncated form, basal cell adhesion molecule (B-CAM). In cell adhesion experiments, Int 1 was crucial for
adhesion to most of the purified human BM proteins. Lu/B-CAM mediated adhesion to Lm-511 together with Int 31, and was essen-
tial for the adhesion of hESCs to embryonic feeder cells. Adhesion to Lm-411 was mediated by Int 61. Lm-511 supported hESC growth
in defined medium equally well as Matrigel. These results provide consequential information of the biological role of BM in hESCs, war-
ranting further investigation of BM biology of human pluripotent stem cells.
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cell–cell and cell–ECM interactions by adhering cells to BM 
proteins. Mouse embryos constitutively express Int V3, 61
and 51 at two-cell stage, and integrins 31, 71, 61, 21
and 11 in a regulated manner during further development [4, 8].
Human embryos express Int V subunit throughout the early
embryonic development, at least until compaction [9]. Embryonic
epithelial cells have been shown to express the dystroglycan
 glycoprotein complex, which can act as a receptor for Lm-111 
[4, 10, 11]. Besides integrins and dystroglycan complex, Lutheran
glycoprotein (Lu/B-CAM) acts as a receptor for 5-chain contain-
ing Lms [12, 13].
Feeder cell-free culturing of human embryonic stem cells
(hESC) typically requires an ECM coating, such as Matrigel,
and supplementation with basic fibroblast growth factor (bFGF)
[14, 15]. A recent study indicated that bFGF might have an indi-
rect effect on hESC cultures via hESC-derived fibroblast-like
cells [16]. Beside other functions, FGFs modify the ECM pro-
duction of cells [17]. Stem cells are located in a specific niche
composed of soluble factors and the physical interactions
between stem cells and the surrounding BM proteins [18, 19].
Because of the origin of hESCs, their in vivo niche is difficult to
explore and there is little information available on the synthe-
sis of BM proteins by hESCs. In order to better understand the
natural ECM of hESCs, we have studied the Lm synthesis by




The studies presented here were performed on Finnish hESC lines FES 29
and FES 30 [20]. The cells were regularly analysed for the expression of
pluripotency markers (tumour recognition antigen [Tra] 1–60 and stage-
specific embryonic antigen [SSEA]3) by flow cytometry and found to be 
positive (85% to 97%). The hESCs were cultured on mouse embryonic
fibroblasts (mEF, isolated from day 12.5 ICR foetuses) in KnockOut
Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen, Carlsbad, CA,
USA), supplemented with 20% KnockOut serum replacement, 0.1 mM 
2-mercaptoethanol, 1 penicillin-streptomycin-L-glutamine, 1 nonessen-
tial amino acids (all from Invitrogen), 1 insulin transferrin selenium (ITS)
liquid media supplement (Sigma, St. Louis, MO, USA) and 6 ng/ml bFGF
(Sigma). hESCs were passaged by trypsin-like enzyme (TrypLE Select,
Invitrogen). Before carrying out the experiments presented here the hESCs
were adapted to feeder-free conditions using mEF-conditioned medium
supplemented with 12 ng/ml bFGF and Matrigel (BD Biosciences, Bedford,
UK) coating as described previously [14]. The feeder-free cultures were
passaged every 5 days by collagenase IV (4–5 min., 20 U/ml [Invitrogen]).
Lms-111 [21] and -511 [22] were purified by immunoaffinity chromatogra-
phy from the culture supernatant of Jar cells. Vitronectin was purified as
described [23]. Defined cultures were performed using purified human 
Lm-111 (8 g/ml), Lm-511 (3.5 g/ml) or vitronectin (4 g/ml) as matrix and
StemPro (Invitrogen) as culture medium using mechanical passaging.
Metabolic labelling and immunoprecipitation 
of culture medium, matrix and cells
hESCs were cultured in Roswell Park Memorial Institute medium (RPMI)
(Sigma) without methionine, serum or serum replacement and supple-
mented with ITS, non-essential amino acids, L-Glutamine and bFGF (see
above) for 30 min. After methionine starvation, 100 Ci of 35S-labelled
methionine (Perkin-Elmer, Waltkam, MA, USA) was added to the medium
and incubated overnight. To identify Lms secreted to the culture medium
the medium was first collected and centrifuged. Then the medium was
supplemented with normal mouse serum and with 0.5% Triton X-100. The
medium was pre-absorbed with GammaBindPlus Sepharose (GBPS) beads
(GE Healthcare-Biosciences, Uppsala, Sweden), followed by centrifugation
and absorbtion with GBPS beads pre-coupled with monoclonal antibodies
(MAb) against human Lm 1, 2, 3, 4 and 5 (Table 1).
Labelled cells were lysed on ice in radioimmunoprecipitation assay (RIPA)
buffer containing 10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 0.1% SDS, 1.0%
Triton X-100, 1% deoxycholate, 5 mM EDTA and protease inhibitor mixture.
The cell sample was cleared by centrifugation. For ECM isolation, the cells
were extracted with 0.5% deoxycholate in 10 mM Tris-HCl, 150 mM NaCl,
1 mM protease inhibitor, pH 8.0. The remaining material was solubilized in
RIPA buffer. The cell samples were supplemented with normal mouse or rat
serum, and ECM specimens with normal mouse serum. The samples from
cells were absorbed to GBPS beads pre-coupled with MAb against Int 3,
5, 6 and 1 subunits (Table 1) and ECM specimens with MAbs to Lm
chains as aforementioned.
After overnight immunoprecipitation, bound proteins from cell and
matrix samples were first washed three times in RIPA buffer and bound 
proteins from medium were washed in phosphate buffered saline (PBS) with
Triton X-100. Then the proteins were eluted to Laemmli’s sample buffer and
analysed by SDS-PAGE. After immunoprecipitation the samples from hESC
culture medium were exposed to Chondroitinase ABC treatment (0.02U
chondroitinase ABC [Sigma] in 50 mM Tris-HCl, pH 8.0, 50 mM sodium
acetate) at 37C for 8 hrs and thereafter treated as other samples. The 
following cell lines were used as positive controls: Jar [21] for Lm-111 and
Lm-511, HPAE [24] or Lm-411, and UT-SCC-43A [25] for Lm-332. The anti-
body was omitted in negative controls.
Flow cytometry
hESCs were collected by trypsin-EDTA (Invitrogen) treatment (4–5 min.), after
which the cells were washed, counted and suspended in FACS staining buffer
(5% foetal calf serum [Promocell, Heidelberg, Germany] in PBS). The cells
were suspended in 50 l of primary MAb solution (Table 1) and incubated on
ice for 45 min. After three washes, the hESCs were incubated for 30 min. on
ice with 2 l of conjugated secondary antibodies, in the dark, washed and
fixed with 0.1% paraformaldehyde in FACS staining buffer. Secondary conju-
gates were phycoerythrin-coupled anti-rat IgM for SSEA-3 (BD Biosciences,
San Jose, CA, USA), fluorescein-isothiocyanate (FITC)-coupled antimouse
IgG or FITC-coupled anti-rat IgG (Invitrogen). The primary antibody was omit-
ted in negative controls. Samples were run by FACSCalibur (BD Biosciences)
using CellQuestPro software (BD Biosciences) and analysed by Flow Jo 
(Tree Star Inc., Ashland, OR, USA) software.
Immunocytochemistry
For indirect immunofluorescence the cells were cultured on glass cover
slips and fixed in methanol at –20C. After washing in PBS the cells were
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incubated with primary antibodies listed in Table 1. FITC-coupled anti-
mouse IgG (Fc-fragment specific [Jackson Immunoresearch, West Grove,
PA, USA]) was used as the secondary antibody, followed by MAb Tra1–60
and finally, after washing, the cells were incubated with goat anti-mouse
AlexaFluor 594 IgM ( chain specific [Invitrogen]). The specimens were
embedded in veronal glycerol buffer (1:1) (pH 8.4) and viewed with an
AX70 Provis fluorescence microscope (Olympus, Tokyo, Japan). Images
were acquired using a computer connected to a cooled digital camera
mounted on the microscope.
RT-PCR and quantitative PCR (qPCR) analysis
Total RNA was extracted using NucleoSpin RNA II kit (Macherey-Nagel,
Düren, Germany) without on-column DNase treatment. DNase treatment
was done separately as we have noticed that separate DNase treatment is
more complete than on-column treatment. After the DNase treatment, RNA
was cleaned by using NucleoSpin RNA Clean-up kit (Macherey-Nagel). 
Total RNA was reverse-transcribed into cDNA by M-MLV Reverse
Transcriptase in RT reaction containing Oligo(dT)15 primers, the mix of all
four dNTPs, and rRNasin (all from Promega, Madison, WI, USA). The
cDNA amount was determined as the synthesized cDNA in a 20 l RT reac-
tion containing 1 g total RNA. PCR was performed in a total volume of 
25 l containing 2.5 l 10 PCR buffer with 15 mM MgCl2, 0.2 l
AmpliTaqGold 5U/l (Applied Biosystems, Foster City, CA, USA), 2 l 
2.5 mM dNTPs mix, 1 l of 10 M mix of forward and reverse primers, 
2 l 50% dimethylsulfoxide (DMSO) and 2 l RT reaction as a cDNA tem-
plate. Polymerase was activated at 95C for 7 min., followed by 36 cycles
of 95C, 20 sec.; 56.5C, 30 sec.; 72C, 30 sec., and the final extension at
72C for 7 min. PCR products were analysed in 2.1% agarose gels. Primers
for human Lu, B-CAM, and cyclophilin G were described earlier [26]. The
PCR product for human Lu (B-CAM variant 1) is 115 bp, for human B-CAM
(variant 2) 109 bp and for human cyclophilin G (CG), 126bp.
MAb clone Specificity Reference Methods
161EB7 Lm 1 chain Virtanen et al. [21] IP
5H2 Lm 2 chain Leivo and Engvall [48] ICC
BM-2 Lm 3 chain Rousselle et al. [49] IP
3H2 Lm 4 chain Wondimu et al. [50] IP
4C7 Lm 5 chain Engvall et al. [51] IP
114DG10 Lm 1 chain Virtanen et al. [52] IP
S5F11 Lm 2 chain Wewer et al. [53] ICC
113BC7 Lm 1 chain Määttä et al. [54] IP
TS2/7 Int 1 subunit Hemler et al. [55] ICC, FC
CLB-10G11 Int 2 subunit Giltay et al. [56] ICC, FC
J143 Int 3 subunit Fradet et al. [57] ICC, IP, FC
PIB5 Int 3 subunit Wayner and Carter [58] FB
PUJI4 Int 4 subunit Hemler et al. [59] ICC, FC
B1E5 Int 5 subunit Werb et al. [60] ICC, IP, FC
GoH3 Int 6 subunit Chemicon, Temecula, CA ICC, IP, FC, FB
LM 142.69 Int v subunit Cheresh and Spiro [61] ICC, FC
13 Int 1 subunit Yamada et al. [62] FB
102DF5 Int 1 subunit Ylänne and Virtanen [63] ICC, IP, FC
90B10 Int 2 subunit Ylänne et al. [64] ICC
AA3 Int 4 subunit Tamura et al. [65] ICC
B5–1A9 Int 5 subunit Pasqualini et al. [66] ICC
BRIC221 Lutheran Serotec, Oxford, England ICC
Tra 1–60 Tra 1–60 Chemicon, Temecula, CA ICC, FC
MC631 SSEA-3 Solter and Knowles [67] Peter Andrews, Sheffield, UK FC
Table 1 Antibodies used in the study
IP; immunoprecipitation, ICC; immunocytochemistry, FC; flow cytometry, FB; function blocking.
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For real-time SYBR (a nucleic acid gel stain) Green qPCR, total RNA
was reverse transcribed as described above. Each multiplication reaction,
run in duplicate, contained 2 l 10 PCR buffer (Applied Biosystems), 
2 l MgCl2 25 mM stock, 1.6 l dNuTPs mix 2.5 mM each (Promega), 1.6 l
DMSO 50% stock, 5 l mix of F/R primers (both 1.4 M in mix), 1 l RT
reaction as a cDNA template, 0.16 l AmpliTaq Gold DNA polymerase 
5 U/L (Applied Biosystems), 0.8 l SYBR Green (1/500 dilution from
stock SYBR Green I nucleic acid gel stain, 10,000 concentrate in DMSO
[Invitrogen]), and DEPC H2O ad 20 l. The reactions for the qPCR were
prepared with a Corbett CAS-1200 liquid handling system and the qPCR
was performed using Corbett Rotor-Gene 6000 (Corbett Life Science,
Sydney, Australia) as follows: enzyme activation step at 95C for 7 min. fol-
lowing 40 cycles of 95C, 20 sec.; 56C, 20 sec.; 72C, 20 sec., followed
by a melting step. Data were analysed according to the comparative Ct
method (		Ct) (Applied Biosystems, User Bulletin #2). Control samples
were hESCs cultured on Matrigel in StemPro medium. The value ‘1’ repre-
sents the control in each qPCR result curve. 
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Quantitative cell adhesion experiments
Fibronectin (Fn) was purified from outdated human plasma (Finnish Red
Cross Blood Service, Helsinki, Finland) by Gelatin Sepharose 4B affinity
chromatography (GE Healthcare-Biosciences), according to Engvall and
Ruoslahti [27]. Recombinant human Lm-411 was produced in a mam-
malian expression system [28]. Lms-111 [21] and -511 [22] were purified
by immunoaffinity chromatography from the culture supernatant of Jar
cells. Soluble recombinant Lutheran (Sol-Lu) corresponding to the extra-
cellular domain of Lu/B-CAM was produced as described [12]. Briefly,
adhesion experiments were performed using a method based on intracel-
lular acid phosphatase assay, as described [29, 30]. Wells of 96-well plates
were first coated with distinct ECM proteins (4 g/ml) at RT for 1 hr and
then with 3% bovine serum albumin at RT for 1 hr. Alternatively, a mono-
layer of mEFs was plated 1 day before performing the experiments. When
indicated, Sol-Lu (10 g/ml) was incubated at RT for 1 hr. Trypsin-EDTA
(Invitrogen) treated hESCs were washed by trypsin neutralizing solution
(Promocell). 2  104 cells per pre-coated well were plated with or without
function blocking (FB) MAbs (Table 1) in hESC medium without serum
replacement. After 2 hrs incubation in standard culture conditions at
37C the wells were washed three times and the attached hESCs were
exposed to phosphatase substrate (104 phosphatase substrate [Sigma], 
6 mg/ml in 50 mM sodium acetate buffer with 0.1% Triton X-100, pH 5.0).
The reaction was stopped with 1M NaOH and absorbances were measured
at 405 nm. Unspecific binding and background were measured by using
either 3% bovine serum albumin treated wells or wells containing only
mEFs. The experiments were performed in triplicate. Results were statisti-
cally analysed with two-tailed Student’s t-test.
Live-cell imaging for the determination of cell
growth rate
hESCs were passaged mechanically from Matrigel to Lm-111, Lm-511,
Vitronectin, Matrigel, or Gelatin- (Sigma) coated 48-wells in StemPro-
medium and let to adhere in a cell culture incubator for 24 hrs. Then, the
culture medium was changed and the culture plate was transferred to a
Cell-IQ Cell Culturing Platform (ChipManTechnologies, Tampere, Finland).
Selected positions of the wells were imaged every hour for 24 hrs. Then,
the images were analysed for colony size and presence of dead cells, using
protocols developed by ChipManTechnologies. Results are presented as
relative changes in cell surface area in three replicate culture wells.
Results
hESCs synthesize and deposit laminins-111 
and -511
First we studied which Lm chains are synthesized by undifferenti-
ated hESCs. By using metabolic labelling and MAbs specific for
human Lm chains, we found that hESCs produce a limited set of
Lm subunits, regardless of the culture conditions. Of the analysed
Lm  chains (1–5), only Lm 1 and 5 could be precipitated
from the culture medium (Fig. 1a and b; Table 2). Also, Lm 1 and
1 chains were precipitated from the medium. To ascertain the
functionality of the Lm chains, we also isolated the ECM produced
by hESCs. These experiments showed that the hESCs deposited
Lm 1, 5, 1 and 1 chains into the matrix (Fig. 1a and b; Table 2).
By contrast, neither Lm 3 nor Lm 4 chains were detected in the
hESC culture medium supernatant (Fig. 1c and d; Table 2) or in the
hESC-ECM material (not shown).
Laminin chain Method Medium Matrix
Lm 1 IP, ICC  
Lm 2 ICC  
Lm 3 IP  
Lm 4 IP, ICC  
Lm 5 IP, ICC  
Lm 1 IP, ICC  
Lm 2 ICC  
Lm 1 IP, ICC  
Table 2 Examined laminin chains and their synthesis in hESCs
IP; immunoprecipitation, ICC; immunocytochemistry.
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Undifferentiated hESCs contain integrin receptors
for laminins
Flow cytometry, immunocytochemistry and immunoprecipitation
analysis were carried out to find out which integrin subunits were
present on hESCs (Fig. 2a and b; Table 3). Immunocytochemistry
analysis was performed together with the pluripotency marker
Tra1–60 to confirm the quality of the cells. Int 1 subunit was
highly expressed, as 99% of the hESCs contained the antigen with
high intensity (Fig. 2a) together with the pluripotency marker
Tra1–60 (Fig. 2b). Lm binding integrin subunits Int 3 (95%) and 6
(98%), were also highly present on hESCs (Fig. 2a and b), while 1
and 2 subunits, specifically binding collagen, could not be found
(Fig. 2a). Int V (Fig. 2a and b) and 5 (Fig. 2b) subunits were
strongly present in prominent point adhesion sites of hESCs (as
suggested by lack of talin and vinculin, not shown), but not else-
where in the cells. Also, Int 5 (90%) was present in most of the
hESCs (Fig. 2a and b) while immunoreactivity for Int 2, 4, 3 or
4 subunits could not be found (not shown). Immunoprecipitation
by MAbs against human integrin subunits confirmed that the hESCs
Fig. 1 Production of laminin (Lm)
chains by hESCs. hESCs were meta-
bolically labelled with radioactive
methionine followed by the immuno-
precipitation of Lm chains. (a) and
(b) hESCs synthesized and secreted
chains of Lm-111 (111) and Lm-
511 (511) into culture medium
and matrix. (c) and (d) hESCs did not
produce Lm-332 or Lm-411. C;
positive control, C–; negative control
without antibody.
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2627© 2008 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 hESCs contain laminin (Lm-), fibronectin- and vitronectin-binding integrins. (a) Flow cytometry analysis showed that hESCs contained Int 1,
3, 6, 5 and V subunits. Int 1 subunit can bind different Lms by pairing with Int 3 and 6 subunits, fibronectin with Int 5 subunit, and vitronectin
with Int V subunit. Functions of fibronectin and vitronectin receptors may overlap. hESCs did not contain collagen binding Integrins 1 and 2. 
(b) hESCs were double-stained by monoclonal antibodies against integrin subunits and Tra1–60 antigen. Tra1–60-positive hESCs showed immunore-
activity for Int 1, 3, 6 and 5 subunits in a cell surface-confined manner (Tra1–60 shown only for Int 1). Int V and 5 subunits were seen as a
pattern resembling point adhesions. Scale bar, 50 m. Immunoprecipitation confirmed production of Int 1, 3, 5 and 6 subunits.
2628 © 2008 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
contained Int 1, 3, 5 and 6 subunits produced by themselves
(Fig. 2b). The results were highly similar in two different hESC lines
in all tested culture conditions. Pluripotency markers Tra1–60 and
SSEA3 were expressed (from 80% to 95%) by both hESC lines
throughout the study (not shown).
Undifferentiated hESCs contain Lutheran
 glycoprotein
MAb against human Lu/B-CAM uniformly stained undifferentiated
hESC colonies with high intensity, together with Tra1–60 (Fig. 3a).
Lu and B-CAM arise from a single mRNA via alternative splicing
and differ in the length of their cytoplasmic tail. Since the antibody
against Lu/B-CAM recognizes both variants of the proteins, we
analysed the expression of these splice variants in hESCs by 
RT-PCR. Both forms of the gene, B-CAM variant 1(Lu) and B-CAM
variant 2(B-CAM), were expressed in hESCs (Fig. 3b).
hESCs adhere to laminin-511 through 
lutheran/B-CAM and Int 31
Next, we performed functional adhesion experiments to quantify
hESC adhesion to distinct ECM and BM proteins in conditions
devoid of serum and serum replacement. The experiments were
performed with hESCs cultured in feeder-free conditions. While
these simplified conditions do not represent true culture condi-
tions, our aim was to decipher interactions between the hESCs
and the BM proteins at the receptor level. Based on findings per-
formed by flow cytometry, immunoprecipitation and immunocyto-
chemistry, we selected function blocking MAbs for certain highly
expressed integrin receptor subunits to find out their functional
properties in the adhesion of hESCs. The cells adhered well to
Matrigel and fibronectin, both of which are known to function as
potent cell adhesion substrata (Fig. 4a). Lu/B-CAM receptor medi-
ates adhesion to Lm 5 chain in many epithelial and endothelial
cells [31]. Hence, we quantified adhesion of hESCs to Lm-511 in
presence of either function-blocking MAb against Int 1 subunit
alone, or function-blocking MAb against Int 3 subunit alone. In
addition, the adhesion was measured in presence of recombinant,
soluble Lutheran (Sol-Lu) alone, or Sol-Lu together with function-
blocking MAb against Int 3 subunit. hESCs adhered strongly to
purified human Lm-511 (Fig. 4b). MAbs against Int 31 and 
Sol-Lu inhibited hESC adhesion, thus suggesting that Lutheran
mediates their adhesion to Lm-511 in cooperation with Int 31
(P  0.001) (Fig. 4b). Then, we quantified the adhesion of hESCs
to mEFs either in presence of MAb against Int 1 or Sol-Lu.
Surprisingly, the adhesion to mEFs was not blocked by MAb
against Int 1, but with sol-Lu (Fig. 4c).
Adhesion to purified human Lm-111 was relatively weak and it
was completely blocked by function-blocking MAb against Int 1
subunit (P  0.005) (Fig. 4d). Function-blocking MAb against Int
6 tended to reduce the adhesion to Lm-111, suggesting that Int
61 may be involved in the adhesion (Fig. 4d). However, this
effect was not statistically significant. Figure 4e shows minor
Table 3 Examined integrin subunits and their presence in hESCs
IP; immunoprecipitation, ICC; immunocytochemistry, FC; flow cytometry.
Integrin subunit Method Localization
Int 1 ICC, FC -
Int 2 ICC, FC -
Int 3 ICC, FC, IP Cell surface
Int 4 ICC, FC -
Int 5 ICC, FC, IP Cell surface
Int 6 ICC, FC, IP Cell surface
Int v ICC, FC Point adhesions
Int 1 ICC, FC, IP Cell surface
Int 3 ICC -
Int 4 ICC -
Int 5 ICC Point adhesions
Fig. 3 Undifferentiated hESCs contain a known Lm 5 receptor,
Lutheran/B-CAM. (a) Antibody against Lutheran/B-CAM intensively
stained Tra1–60-positive hESCs. Scale bar, 50 m. (b) Both mRNA vari-
ants of the same gene, 115 bp for Lutheran and 109 bp for B-CAM, were
expressed by hESCs. Negative controls; C1 for Lutheran, C2 for B-CAM,
C3 for Cyclophilin G.
J. Cell. Mol. Med. Vol 13, No 8B, 2009
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hESC adhesion to Lm-411, which was completely blocked by
function-blocking MAb against either Int 1 (P  0.001) or Int 6
(P  0.005), suggesting that adhesion is mediated via Int 61.
The adhesion of hESCs to purified human fibronectin and Matrigel
was also significantly reduced by the Int 1 antibody (results not
shown). The results were similar when the hESCs were cultured
on mEFs.
BM proteins differ in their ability to maintain
hESC self-renewal
We measured hESC proliferation on Lm-111, Lm-511 or vit-
ronectin in defined culture conditions. Cell growth was measured
by changes in the hESC colony surface area in function of time
with simultaneous monitoring of cellular morphology. The prolif-
eration rates detected on hESCs growing on Matrigel or purified
human Lm-511 were highly comparable (Fig. 5a). Also vitronectin
could support the growth, whereas proliferation was weak on puri-
fied human Lm-111 and no proliferation was detected on gelatin
(Fig. 5a). We then cultured hESCs for 5 passages on either  
Lm-111, Lm-511, or on heparin-binding form of vitronectin 
(all purified from human sources) in StemPro culture medium.
Typical undifferentiated morphology persisted on Lm-511 (Fig. 5b,
II and V) and on vitronectin (Fig. 5b, III and VI). However, distinct
differentiation events occurred on Lm-111 (arrows in Fig. 5b, I and IV).
In order to further verify the self-renewal capacity of the hESCs
under the defined culture conditions we quantified gene expres-
sion levels of pluripotency marker genes Sox2 and Oct4, and early
differentiation marker genes, Brachyury (Bra) and Goosecoid
(GSC). Matrigel with StemPro was used as the reference culture
condition, representing the value ‘1’ in each qPCR panel (Fig. 5c).
The expression levels of Sox2 and Oct4 remained relatively stable
in all conditions (Fig. 5c). However, the levels of Bra and GSC
decreased during culture on Lm-511 or vitronectin. In contrast,
hESCs tended to differentiate when cultured on Lm-111, as shown
by increased expression of both Bra and GSC (Fig. 5c).
Discussion
Stem cell niches composed of neighbouring cells, ECM proteins,
and soluble factors have been recognized crucial for regulating
tissue specific stem cell self-renewal and differentiation [32–34]
and it has been proposed that ECM has an important regulatory
role also for the hESC niche [35, 36]. In this study, we have
analysed the production of Lm chains and the ECM and BM
receptors by hESCs and further investigated the functional role 
of these receptors in adhesion to purified human BM proteins.
We show that Lm isoforms differ in their ability to support hESC
Fig. 4 hESC adhesion to BM proteins was measured by quan-
titative adhesion experiments. Monoclonal antibodies (MAb)
directed against various receptors, or recombinant Lutheran
(Sol-Lu) were used to determine functional receptors in
hESCs. (a) hESCs adhered potently to positive control sub-
strata, Matrigel and fibronectin. (b) Prominent hESC adhesion
to purified human Lm-511 was mediated via Int 1, 3 and Sol-
Lu (P  0.001). (c) Sol-Lu, but not MAb against Int 1, totally
blocked adhesion to mEFs. (d) and (e) Adhesion to Lm-111 or
to Lm-411 was poor. MAb against Int 1 prevented 
(P  0.005) adhesion to Lm-111. MAbs against Int 1 and 6
blocked adhesion to Lm-411 (P  0.001; P  0.005).
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Fig. 5 Individual laminin isoforms have distinct effects on the hESC self-renewal. (a) Proliferation was measured in a continuous live-cell imaging 
system. The area of hESC colonies in relative units is shown in function of time (hours). Results are presented as the mean  S.E.M. for three culture
wells. The growth rate was highest on Matrigel and on purified human Lm-511. In contrast, proliferation on Lm-111 was low. (b) hESCs cultured on
purified human Lm-111 (I and IV), Lm-511 (II and V) or Vn (III and VI) in defined medium, StemPro, at passage 5. hESCs tended to differentiate on
human Lm-111 (I, IV; arrows) whereas typical characteristics of undifferentiated cells were present on Lm-511 and on Vn. Scale bars, 100 m. 
(c) qPCR analysis of hESCs cultured on BM proteins in StemPro, at passage 1, 3 and 5. The relative expression levels of the pluripotency marker genes,
Sox2 and Oct4 sustained, while the expression of the differentiation markers GSC and Bra decreased during culture on Lm-511 or Vn. In contrast,
 differentiation occurred when the hESCs were cultured on Lm-111, as shown by the presence of GSC and Bra and a decreasing level of Oct4. Data are
presented as the mean expression level relative to cells grown on Matrigel, determined in duplicate.
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proliferation and/or maintain their undifferentiated state, even in
short-term culture.
Our results show that hESCs produce Lm 1, 5, 1 and, 1
chains and that those chains are also deposited as Lms-111 and 
-511 into hESC-produced ECM. According to our flow cytometry,
immunocytochemistry and immunoprecipitation analyses the
undifferentiated hESCs selectively contain Lm binding integrin 1,
3 and 6 subunits. In contrast, 1, 2 and 4 integrin subunits
involved in collagen and/or Lm binding could not be detected in
hESCs (not shown). Functional adhesion experiments confirmed
that hESCs do adhere both to Lm-111 and Lm-511 utilizing their
specific integrin receptors. In short-term culture experiments
especially Lm-511 seemed to support both self-renewal and pro-
liferation of hESCs. The early differentiation markers, Brachyury
and Goosecoid, were declined during cultures on Lm-511 further
strengthening its role as a biologically relevant BM component for
undifferentiated hESCs. Supporting this, it has recently been
shown that Lm-511 supports the self-renewal of mouse ES cells
[37]. In contrast, Lm-111 as such did not support growth or self-
renewal of the undifferentiated hESCs, as the same differentiation
markers were constantly present when the hESCs were cultured
on Lm-111. Whether Lm-111 has a role alone or in combination
with other BM components in the maintenance or early differenti-
ation of hESCs remains to be elucidated.
In previous studies, hESCs have been shown to have character-
istics typical for epithelial cells [38–40]. Specifically, cells covering
hESC colonies have a polarized structure and contain epithelial pro-
teins, e.g. E-cadherin. Of the studied BM proteins, Lm-111 and Lm-
511 are, besides embryonic, also typical epithelial Lms. The same
Lm chains have been shown to be essential for the formation of the
embryonic BM and survival of the mouse embryo [6, 7]. 
It has also been suggested for mice that if the embryonic BM
is not correctly formed, ICM cells are not able to polarize towards
embryonic epiblastic cells, normally occurring prior to gastrula-
tion [41, 42]. Thereby, it is reasonable that hESCs, as epithelial
epiblast-like cells, produce and deposit embryonic Lm chains.
Taken together, we suggest that Lm-111, and especially Lm-511,
are functionally important Lms for hESCs.
Majority of the hESCs showed intensive staining for Int 5, V
and 5 subunits that in conjunction with Int 1 are known to form
a set of functional fibronectin and vitronectin receptors. The func-
tionality of these integrins was also confirmed by adhesion and
short term culture assays. Our results are in good agreement with
previous studies, showing that both fibronectin and vitronectin
can support hESCs in long-term cultures [15, 43]. There are only
few studies about the expression of integrins or Lms in early
human embryos, the closest in vivo equivalents to hESC. In blas-
tocyst/implantation stage of human embryos, a mainly trophecto-
dermal expression of Int 1, 5 and 6 subunit proteins has been
detected [44]. The human blastocyst also produces the Int V sub-
unit [9]. There is no evidence of the role of integrins in the com-
mitment or maintenance of the ICM or trophectodermal cells and
no data are available about the epiblastic/hypoblastic differentia-
tion in the human embryo. An analysis of integrin expression of
hESCs has recently appeared [43]. The only major difference
between the results of Braam et al. and our study is that we did
not detect immunoreactivity for Int 2. 
Low Int 2 level has also been reported based on gene expres-
sion data [45]. The integrin 1 subunit is known to have a central
role in various mammalian cell types and it was also found to be
involved in interactions between hESCs and all the explored
BM/ECM components in this study. The use of MAb blocking Int
1 function prevented the adhesion to BM proteins nearly totally.
Blocking of Int 6 subunit function with MAb totally prevented
hESC adhesion to Lm-411. The result is in line with the results that
Int 61 functions as a receptor for Lm-111 in mouse embryonic
and human epithelial cells [4, 21] as well as for Lm-411 in human
endothelial cells [24].
Interestingly, hESCs showed a high content of Lutheran/
B-CAM (Lu/B-CAM) glycoprotein on their surface. Lu/B-CAM is a
transmembrane receptor of the immunoglobulin superfamily and
it is known to mediate cell adhesion to Lms-511 and -521 inde-
pendently or in concert with integrins [31, 46]. Our results 
show that independently of culture conditions hESC adhesion to
Lm-511 is mediated via cooperation of Lu/B-CAM and Int 31.
Importantly, Sol-Lu also blocked hESC adhesion to mEFs in adhe-
sion experiments. This is consistent with our unpublished obser-
vation that mEFs produce large amounts of Lm-511, the target of
Lu/B-CAM. Little is known about the role of Lu/B-CAM in early
development. However, mice lacking Lutheran are viable, without
severe defects [47]. The exact role of Lu/B-CAM in hESC biology
and culture adaptation remains to be examined.
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